Connor, Clark & Lunn Investment Management Ltd. Orasure Technologies Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Orasure Technologies Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 28,731 shares of OSUR stock, worth $111,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,731

Previous 16,127 78.15%

Holding current value

$111,476

Previous $68,000 79.41%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$3.93 - $4.59 $49,533 - $57,852	12,604 Added 78.15%	28,731 $122,000
Q2 2024 Aug 09, 2024	SELL	$4.2 - $6.18 $422,242 - $621,300	-100,534 Reduced 86.18%	16,127 $68,000
Q1 2024 May 09, 2024	SELL	$6.08 - $8.28 $619,175 - $843,218	-101,838 Reduced 46.61%	116,661 $717,000
Q4 2023 Feb 09, 2024	SELL	$5.13 - $8.35 $400,883 - $652,510	-78,145 Reduced 26.34%	218,499 $1.79 Million
Q3 2023 Nov 13, 2023	BUY	$4.4 - $6.91 $1.19 Million - $1.87 Million	270,966 Added 1055.25%	296,644 $1.76 Million
Q2 2023 Aug 10, 2023	SELL	$4.88 - $7.39 $884,158 - $1.34 Million	-181,180 Reduced 87.59%	25,678 $128,000
Q1 2023 May 09, 2023	BUY	$4.66 - $6.52 $256,360 - $358,684	55,013 Added 36.23%	206,858 $1.25 Million
Q4 2022 Feb 10, 2023	BUY	$3.7 - $5.29 $267,665 - $382,689	72,342 Added 90.99%	151,845 $731,000
Q3 2022 Nov 10, 2022	BUY	$2.72 - $4.61 $216,248 - $366,508	79,503 New	79,503 $301,000
Q4 2021 Feb 10, 2022	SELL	$8.3 - $11.29 $323,260 - $439,711	-38,947 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.73 - $13.38 $378,954 - $521,110	38,947 New	38,947 $440,000

Others Institutions Holding OSUR

# of Institutions

202

Shares Held

65.5M

Call Options Held

2.2K

Put Options Held

5.1K

View Full List

About ORASURE TECHNOLOGIES INC

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $282M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

More about OSUR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Orasure Technologies Inc Transaction History